RU2001107031A - TRANSGENESIS IN MAMMALS BY INTRACYTOPLASMATIC Sperm Injection - Google Patents

TRANSGENESIS IN MAMMALS BY INTRACYTOPLASMATIC Sperm Injection

Info

Publication number
RU2001107031A
RU2001107031A RU2001107031/13A RU2001107031A RU2001107031A RU 2001107031 A RU2001107031 A RU 2001107031A RU 2001107031/13 A RU2001107031/13 A RU 2001107031/13A RU 2001107031 A RU2001107031 A RU 2001107031A RU 2001107031 A RU2001107031 A RU 2001107031A
Authority
RU
Russia
Prior art keywords
sperm head
oocyte
membrane
sperm
transgenic
Prior art date
Application number
RU2001107031/13A
Other languages
Russian (ru)
Other versions
RU2267270C2 (en
Inventor
Рюзо ЯНАГИМАЧИ
Энтони С. Ф. ПЕРРИ
Original Assignee
Юнивесити Оф Гаваи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнивесити Оф Гаваи filed Critical Юнивесити Оф Гаваи
Publication of RU2001107031A publication Critical patent/RU2001107031A/en
Application granted granted Critical
Publication of RU2267270C2 publication Critical patent/RU2267270C2/en

Links

Claims (21)

1. Способ получения трансгенного эмбриона, включающий стадии совместного введения экзогенной нуклеиновой кислоты и головки спермия с разрушенной мембраной или головки спермия с удаленной мембраной в неоплодотворенный ооцит с образованием трансгенного оплодотворенного ооцита и предоставления трансгенному оплодотворенному ооциту возможности развиться в трансгенный эмбрион.1. A method for producing a transgenic embryo, comprising the steps of co-administering an exogenous nucleic acid and a sperm head with a destroyed membrane or a sperm head with a removed membrane into an unfertilized oocyte to form a transgenic fertilized oocyte and allowing the transgenic fertilized oocyte to develop into a transgenic embryo. 2. Способ по п.1, в котором стадию совместного введения выполняют пьезоэлектрически возбуждаемой микроинъекцией.2. The method according to claim 1, in which the stage of co-administration is performed by piezoelectrically excited microinjection. 3. Способ по п.2, в котором экзогенную нуклеиновую кислоту и головку спермия с разрушенной мембраной совместно инъецируют в цитоплазму неоплодотворенного ооцита.3. The method according to claim 2, in which exogenous nucleic acid and a sperm head with a destroyed membrane are jointly injected into the cytoplasm of an unfertilized oocyte. 4. Способ по п.1, в котором головку спермия с разрушенной мембраной получают от сперматозоида, который был заморожен и разморожен.4. The method according to claim 1, in which the sperm head with a destroyed membrane is obtained from a sperm that has been frozen and thawed. 5. Способ по п.1, в котором головку спермия с разрушенной мембраной получают от регидратированного лиофилизированного сперматозоида.5. The method according to claim 1, in which the sperm head with a destroyed membrane is obtained from rehydrated lyophilized sperm. 6. Способ по п.1, в котором головка спермия является лишенной мембраны головкой, содержащей ядро и перинуклеарные материалы.6. The method according to claim 1, in which the sperm head is a membrane-free head containing a core and perinuclear materials. 7. Способ по п.6, в котором головку спермия с разрушенной мембраной получают от сперматозоида, обработанного детергентом.7. The method according to claim 6, in which the sperm head with a destroyed membrane is obtained from a sperm treated with a detergent. 8. Способ по п.1, в котором неоплодотворенный ооцит является ооцитом на стадии метафазы II.8. The method according to claim 1, in which the unfertilized oocyte is an oocyte at the stage of metaphase II. 9. Способ по п.1, в котором стадия совместного введения включает подстадию преинкубации головки спермия с разрушенной мембраной или удаленной мембраной с экзогенной нуклеиновой кислотой в течение первого промежутка времени.9. The method according to claim 1, wherein the co-administration step comprises the step of preincubating a sperm head with a destroyed membrane or a remote membrane with exogenous nucleic acid for a first time period. 10. Способ по п.9, в котором первый промежуток времени составляет примерно от 30 с до, примерно, 5 мин.10. The method according to claim 9, in which the first period of time is from about 30 s to about 5 minutes 11. Способ по п.10, в котором первый промежуток времени составляет примерно от 45 с до, примерно, 3 мин.11. The method according to claim 10, in which the first period of time is from about 45 s to about 3 minutes 12. Способ по п.11, в котором первый промежуток времени составляет примерно от 1 до, примерно, 3 мин.12. The method according to claim 11, in which the first period of time is from about 1 to about 3 minutes 13. Способ по п.1, в котором экзогенная нуклеиновая кислота содержит более одного трансгена.13. The method according to claim 1, in which the exogenous nucleic acid contains more than one transgene. 14. Способ по п.1, дополнительно включающий стадию предоставления возможности трансгенному эмбриону развиться в живого потомка.14. The method of claim 1, further comprising the step of allowing the transgenic embryo to develop into a living descendant. 15. Способ по п.14, в котором стадия предоставления возможности включает подстадию пересадки трансгенного эмбриона в суррогатную мать.15. The method of claim 14, wherein the step of enabling comprises the step of transplanting a transgenic embryo into a surrogate mother. 16. Способ по п.1, в котором ооцит и головка спермия получены от млекопитающего.16. The method according to claim 1, in which the oocyte and sperm head obtained from a mammal. 17. Способ по п.15, в котором млекопитающее выбрано из группы, включающей приматов, овец, быков, свиней, медведей, кошек, собак, лошадей и грызунов.17. The method according to clause 15, in which the mammal is selected from the group comprising primates, sheep, bulls, pigs, bears, cats, dogs, horses and rodents. 18. Способ по п.1, в котором ооцит и головка спермия получены от беспозвоночного.18. The method according to claim 1, in which the oocyte and sperm head obtained from invertebrate. 19. Способ по п.1, в котором ооцит и головка спермия получены от рыбы, амфибии, рептилии или птицы.19. The method according to claim 1, in which the oocyte and sperm head obtained from fish, amphibians, reptiles or birds. 20. Способ по п.1, в котором ооцит и головка спермия получены от морского ежа, лобстера, оболочника, или моллюска.20. The method according to claim 1, in which the oocyte and sperm head are obtained from a sea urchin, lobster, shell, or mollusk. 21. Способ получения трансгенного эмбриона, включающий стадии получения головки спермия с разрушенной мембраной или головки спермия с удаленной мембраной смешивания головки спермия с разрушенной мембраной или головки спермия с удаленной мембраной с экзогенной нуклеиновой кислотой, несущей желаемый ген совместной инъекции смеси в изолированный неоплодотворенный ооцит на стадии метафазы II с образованием трансгенного оплодотворенного ооцита и предоставление трансгенному оплодотворенному ооциту возможности развиться в трансгенный эмбрион.21. A method for producing a transgenic embryo, comprising the steps of producing a sperm head with a destroyed membrane or a sperm head with a removed membrane; mixing a sperm head with a destroyed membrane or a sperm head with a removed membrane with an exogenous nucleic acid carrying the desired gene for joint injection of the mixture into an isolated unfertilized oocyte at the stage metaphase II to form a transgenic fertilized oocyte and enable the transgenic fertilized oocyte to develop into a transgenic em brion.
RU2001107031/13A 1998-08-11 1999-08-10 Transgenesis due to intracytoplasmatic spermatic injection in mammalians RU2267270C2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9607898P 1998-08-11 1998-08-11
US60/096,078 1998-08-11
US13397099P 1999-05-13 1999-05-13
US60/133,970 1999-05-13
US603/133,970 1999-05-13
USPCT/US99/18118 1999-08-10

Publications (2)

Publication Number Publication Date
RU2001107031A true RU2001107031A (en) 2003-08-27
RU2267270C2 RU2267270C2 (en) 2006-01-10

Family

ID=26791039

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001107031/13A RU2267270C2 (en) 1998-08-11 1999-08-10 Transgenesis due to intracytoplasmatic spermatic injection in mammalians

Country Status (16)

Country Link
US (1) US6376743B1 (en)
EP (1) EP1105469B1 (en)
JP (1) JP3830760B2 (en)
CN (1) CN1334870A (en)
AT (1) ATE483017T1 (en)
AU (1) AU772190B2 (en)
BR (1) BR9913643A (en)
CA (1) CA2340199A1 (en)
DE (1) DE69942804D1 (en)
DK (1) DK1105469T3 (en)
HK (1) HK1044174A1 (en)
IL (1) IL141309A0 (en)
MX (1) MXPA01001389A (en)
NZ (1) NZ509634A (en)
RU (1) RU2267270C2 (en)
WO (1) WO2000009674A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030079240A1 (en) * 1997-12-18 2003-04-24 Newman Stuart A. Chimeric embryos and animals containing human cells
US7241617B2 (en) * 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
US20040088748A1 (en) * 1999-05-13 2004-05-06 Perry Anthony C.F. Method of performing transgenesis
US20010044937A1 (en) * 1999-12-17 2001-11-22 Gerald Schatten Methods for producing transgenic animals
US7094601B2 (en) * 2000-05-16 2006-08-22 The General Hospital Corporation Microinjection of cryoprotectants for preservation of cells
US20020045156A1 (en) * 2000-05-16 2002-04-18 Mehmet Toner Microinjection of cryoprotectants for preservation of cells
US20040040051A1 (en) * 2001-01-19 2004-02-26 Whitehead Institute For Biomedical Research Generation of non-human mammals by nuclear cloning
US20080124787A1 (en) * 2001-02-13 2008-05-29 Avigenics, Inc. Microinjection devices and methods of use
US7339090B2 (en) 2001-02-13 2008-03-04 Avigenics, Inc. Microinjection devices and methods of use
US20020116732A1 (en) * 2001-02-13 2002-08-22 Leandro Christmann Microinjection assembly and methods for microinjecting and reimplanting avian eggs
EP1438401B1 (en) 2001-09-18 2011-06-15 Synageva BioPharma Corp. Production of a transgenic avian by cytoplasmic injection
US7550650B2 (en) 2001-09-18 2009-06-23 Synageva Biopharma Corp. Production of a transgenic avian by cytoplasmic injection
US20040210955A1 (en) * 2001-10-26 2004-10-21 Hidenori Akutsu Preparation of spermatozoa for ICSI-mediated transgenesis and methods of using the same
US20040006157A1 (en) * 2002-04-26 2004-01-08 Gloster Daniel F. Ultra violet curable 100 percent solids inks
US20040172667A1 (en) * 2002-06-26 2004-09-02 Cooper Richard K. Administration of transposon-based vectors to reproductive organs
US20040235011A1 (en) * 2002-06-26 2004-11-25 Cooper Richard K. Production of multimeric proteins
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
US8071364B2 (en) 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
AU2005226779B8 (en) 2004-02-24 2011-03-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rab9A, Rab11A, and modulators thereof related to infectious disease
ES2245591B1 (en) * 2004-04-06 2007-04-01 Consejo Sup. Investigaciones Cientificas NEW PROCEDURE FOR GENERATING NON-HUMAN TRANSGENIC ANIMALS, AND THE TRANSGENIC ANIMALS SO OBTAINED.
US20060294606A1 (en) * 2004-05-18 2006-12-28 Istefo Moisyadi Tn5 transposase-mediated transgenesis
US20060130157A1 (en) 2004-10-22 2006-06-15 Kevin Wells Ungulates with genetically modified immune systems
CA2585970A1 (en) 2004-10-27 2006-05-04 Vanderbilt University Mammalian genes involved in infection
CA2909775A1 (en) 2005-08-09 2007-03-29 Revivicor, Inc. Transgenic ungulates expressing ctla4-ig and uses thereof
US20100272706A1 (en) 2007-06-22 2010-10-28 Jason Mercer Antivirals
WO2010036979A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of interferon
US9150880B2 (en) * 2008-09-25 2015-10-06 Proteovec Holding, L.L.C. Vectors for production of antibodies
WO2010036978A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
ES2548377T3 (en) 2008-10-27 2015-10-16 Revivicor, Inc. Immunosuppressed ungulates
WO2010118360A1 (en) * 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
WO2010144611A2 (en) * 2009-06-10 2010-12-16 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels
US10202615B2 (en) 2010-12-10 2019-02-12 Vanderbilt University Mammalian genes involved in toxicity and infection
ES2680636T3 (en) 2011-02-14 2018-09-10 Revivicor Inc. Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
US20150025306A1 (en) * 2013-07-19 2015-01-22 Elwha Llc Methods and Systems for Utilizing Sperm for Molecular Delivery
US20150024497A1 (en) * 2013-07-19 2015-01-22 Elwha Llc Methods and Systems for Utilizing Sperm for Molecular Delivery
RU2613788C1 (en) * 2015-12-15 2017-03-21 Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Method for trophoblast cells biopsy at multiplicity of cells that do not participate in compaction at blastocyst stage for human embryos preimplantation genetic screening programmes
WO2018015497A2 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2019113743A1 (en) * 2017-12-11 2019-06-20 清华大学 Genetic modification method
KR102036723B1 (en) 2018-02-09 2019-11-26 재단법인 대구경북과학기술원 Intracytoplasmic sperm injection system and method of sperm injection
CN114667141A (en) 2019-09-03 2022-06-24 奥布赛瓦股份公司 Oxytocin antagonist dosing regimen for promotion of embryo transfer and prevention of miscarriage
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
WO2023250101A1 (en) 2022-06-22 2023-12-28 Gameto, Inc. Compositions and methods for inducing oocyte maturation
US11744920B1 (en) 2022-08-12 2023-09-05 Gameto, Inc Implant for ovarian decline and methods of manufacturing an implant for ovarian decline
WO2024054644A2 (en) 2022-09-09 2024-03-14 Gameto, Inc. Production and applications of ovarian and uterine organoids
WO2024206245A1 (en) 2023-03-24 2024-10-03 Gameto, Inc. Methods and compositions for producing ovarian support cell co-culture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641526B1 (en) * 1998-03-20 2003-11-04 University Of Hawaii Development of normal offspring from oocytes injected with freeze-dried spermatozoa
NZ509861A (en) 1998-08-11 2004-01-30 Teruhiko Wakayama Method of performing transgenesis

Similar Documents

Publication Publication Date Title
RU2001107031A (en) TRANSGENESIS IN MAMMALS BY INTRACYTOPLASMATIC Sperm Injection
Deng et al. Use of the 2A peptide for generation of multi-transgenic pigs through a single round of nuclear transfer
Kues et al. Advances in farm animal transgenesis
Jin et al. Surrogate broodstock to enhance biotechnology research and applications in aquaculture
CN1250715C (en) Unactivated oocytes as cytoplast recipients for nuclear transfer
Tonelli et al. Progress and biotechnological prospects in fish transgenesis
ATE424108T1 (en) DEVELOPMENT OF ANIMALS FROM ENECURATED OVA RECONSTITUTED WITH ADULT SOMATIC CELL NUCLEARS
Leibo et al. Production of transgenic mice from cryopreserved fertilized ova
Nakamura Avian biotechnology
Houdebine Transgenesis to improve animal production
Hew Transgenic fish: present status and future directions
Yamamoto et al. Establishment of a stable transgenic strain in a pelagic egg spawning marine teleost, Nibe croaker Nibea mitsukurii
YOSHIZAKI Gene transfer in salmonidae: applications to aquaculture
Yang et al. Cock Spermatozoa Serve as the Gene Vector for Generation of ransgenic Chicken (Gallus gallus)
AU673990B2 (en) Repopulation of testicular seminiferous tubules with foreign cells
Tada et al. Production of transgenic mice by microinjection of DNA into vitrified pronucleate stage eggs
Niemann et al. Production of biopharmaceuticals in transgenic animals
Long Dawn of the Deed
Inoue et al. Improved postimplantation development of rabbit nuclear transfer embryos by activation with inositol 1, 4, 5-trisphosphate
US20040210955A1 (en) Preparation of spermatozoa for ICSI-mediated transgenesis and methods of using the same
Bondioli et al. Transgenic livestock
John Clark Generation of transgenic livestock by pronuclear injection
Houdebine Transgenic animal production
JP4036608B2 (en) Clone non-human animal production method
Teymoornejad et al. Transfection of Holstein bull spermatozoa by lipofectamine.